FinancialAdvisor's College Class (FACC)

[FinancialAdvisor]

Alexion Pharma posts wider Q4 loss, sees '06 deficit

*Alexion declined -3.99% on Wednesday, October 5th...

Market Pulse: Alexion Pharma posts wider Q4 loss, sees '06 deficit
Wednesday October 5, 6:48 am ET
By Robert Daniel

NEW YORK (MarketWatch) -- Alexion Pharmaceuticals Inc., Cheshire, Conn., reported a wider fourth-quarter loss and projected a net loss for fiscal 2006. The deficit for the quarter ended July 31 widened to $32.6 million, or $1.16 a share, from $20.1 million, or 88 cents, for the year-earlier period. Revenue was $203,000 compared to $4.15 million; a year earlier, Alexion recognized a $4 million milestone payment from Procter & Gamble Pharmaceuticals related to the APEX-AMI trial. Alexion is managing four Phase III clinical trials involving its lead drug candidates, eculizumab and pexelizumab. Alexion projects a fiscal 2006 net loss of $115 million to $130 million. Alexion shares rose a nickel to $28.08 on Tuesday.


LINK: http://biz.yahoo.com/cbsmb/051005/af4bc796dbc74c35899316a827e6983a.html?.v=1